RSV, Influenza, and SARS-CoV-2 Outcomes in Severely Immunosuppressed Adults
RSV, Influenza, and SARS-CoV-2 Outcomes in Severely Immunosuppressed Adults
Active, not recruiting · NCT07816471 · Registry updated 2026-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| RSV, Influenza, and SARS-CoV-2 Outcomes in Severely Immunosuppressed Adults | COVID-19, Coronaviridae Infections, Cytopenia, Hemic and Lymphatic Diseases, Infections, Mononegavirales infectious disease, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, agranulocytosis, hematologic disorder, immune system disorder, inborn error of immunity, influenza, leukocyte disorder, leukopenia, lung disorder, lymphopenia, neutropenia, pneumonia, respiratory syncytial virus infectious disease, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Not stated | 2026-09-11 | NCT07816471 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hospital Italiano de Buenos Aires | 20 |
| Pfizer | 431 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||